In AD, spreading of the neurofibrillary lesions in the cortex (first enthorinal cortex, then hippocampus and lastly neocortex) fits to the progression of the symptoms, supporting that Tau pathology is indeed instrumental in cognitive alterations (for review Colin et al., 2020). This evidence concerns the gene MAPT and Alzheimer disease.